Literature DB >> 4278001

Assay of 5-fluorodeoxyuridine 5'-monophosphate deoxyuridine 5'-monophosphate pools following 5-fluorouracil.

C E Myers, R C Young, D G Johns, B A Chabner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4278001

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  6 in total

1.  Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determination of 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthetase.

Authors:  R G Moran; C P Spears; C Heidelberger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

Review 2.  In vivo 19F nuclear magnetic resonance spectroscopy: a potential monitor of 5-fluorouracil pharmacokinetics and metabolism.

Authors:  J L Evelhoch
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

3.  Biochemical determinants of 5-fluorouracil response in vivo. The role of deoxyuridylate pool expansion.

Authors:  C E Myers; R C Young; B A Chabner
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

4.  Sequential methotrexate/5-FU: FdUMP formation and TS inhibition in a transplantable rodent colon adenocarcinoma.

Authors:  M H Berne; B G Gustavsson; O Almersjö; P C Spears; R Frösing
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Death of intestinal crypts and of their constituent cells after treatment by chemotherapeutic drugs.

Authors:  J V Moore
Journal:  Br J Cancer       Date:  1984-01       Impact factor: 7.640

6.  Competitive binding radioassay for the determination of 5-fluorodeoxyuridine and 5-fluorodeoxyuridine-5'-monophosphate levels in plasma and tumor tissue.

Authors:  S Miyata; H Mikami; M Tai; T Hori; H Fujita
Journal:  Jpn J Cancer Res       Date:  1991-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.